Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | TYR | P14679 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.32 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.32 |
| ▸ | HSPA5 | P11021 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29659210 | 1.00 | CYP3A4 (0.36) | CYP3A4CYP2D6CA12CA9ALDH1A1 | |
| SCHEMBL4889490 | 0.88 | CYP3A4 (0.34) | CYP3A4CYP2D6CA12CA9PTGS1 | |
| SCHEMBL30250913 | 0.86 | CYP3A4 (0.32) | CYP3A4CYP2D6ALDH1A1CA2POLB | |
| SCHEMBL1905083 | 0.86 | CYP3A4 (0.32) | CYP3A4CYP2D6ALDH1A1CA2POLB | |
| SCHEMBL5090636 | 0.86 | RXRA (0.31) | CA12CA9HSD17B10 | |
| SCHEMBL5083884 | 0.86 | MEN1 (0.33) | CA12CA9ALDH1A1SMN1; SMN2HSD17B10 | |
| SCHEMBL4887381 | 0.84 | CYP3A4 (0.31) | CYP3A4CYP2D6 | |
| SCHEMBL4887287 | 0.84 | CYP3A4 (0.32) | CYP3A4CYP2D6 | |
| SCHEMBL5083979 | 0.84 | CA1 (0.37) | ALDH1A1CA2SMN1; SMN2PTGS1PTGS2 | |
| SCHEMBL9255038 | 0.83 | CYP2D6 (0.43) | CYP3A4CYP2D6CA12CA9ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240392044-A1 | OLEFIN POLYMERIZATION CATALYST SYSTEM AND POLYMERIZATION PROCESS | NOVA CHEMICALS (INTERNATIONAL) S.A. (CH) | 2024-11-28 | — | — | US | disclosed |
| CN-117980314-A | Olefin polymerization catalyst system and polymerization process | 诺瓦化学品(国际)股份有限公司 | 2024-05-03 | — | — | CN | disclosed |
| US-11339230-B2 | Transition metal compound, catalyst composition including the same, and method for preparing ethylene homopolymer or copolymer of ethylene and α-olefin using the same | SABIC SK NEXLENE COMPANY PTE. LTD. (SG) | 2022-05-24 | — | — | US | disclosed |
| US-20210139617-A1 | NOVEL TRANSITION METAL COMPOUND, CATALYST COMPOSITION INCLUDING THE SAME, AND METHOD FOR PREPARING ETHYLENE HOMOPOLYMER OR COPOLYMER OF ETHYLENE AND ALPHA-OLEFIN USING THE SAME | SABIC SK NEXLENE COMPANY PTE. LTD. (SG) | 2021-05-13 | — | — | US | disclosed |
| WO-2019038605-A1 | NOVEL TRANSITION METAL COMPOUND, CATALYST COMPOSITION INCLUDING THE SAME, AND METHOD FOR PREPARING ETHYLENE HOMOPOLYMER OR COPOLYMER OF ETHYLENE AND α-OLEFIN USING THE SAME | SABIC SK NEXLENE COMPANY PTE. LTD. (SG) | 2019-02-28 | — | — | WO | disclosed |
| WO-2019038605-A1 | NOVEL TRANSITION METAL COMPOUND, CATALYST COMPOSITION INCLUDING THE SAME, AND METHOD FOR PREPARING ETHYLENE HOMOPOLYMER OR COPOLYMER OF ETHYLENE AND α-OLEFIN USING THE SAME | SABIC SK NEXLENE COMPANY PTE. LTD. (SG) | 2019-02-28 | — | — | WO | disclosed |
| US-8084559-B2 | Ethylene-vinylcyclohexane copolymers | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-12-27 | — | — | US | disclosed |
| EP-1475383-B1 | TRANSITION METAL COMPLEXES, LIGANDS, POLYMERIZATION CATALYSTS FOR OLEFINS, AND PROCESS FOR PRODUCTION OF OLEFIN POLYMERS | SUMITOMO CHEMICAL CO (JP) | 2010-09-08 | — | — | EP | disclosed |
| US-20080161514-A1 | Transition Metal Complex, Process For Producing Said Transition Metal Complex, Substituent-Carrying Fluorene Compound, Process For Producing Said Fluorene Compound, Catalyst Component For Olefin Polymerization, Catalyst For Olefin Polymerization, and Process For Producing Olefin Polymer | SUMITOMO CHEMICAL COMPANY, LIMTIED (JP) | 2008-07-03 | — | — | US | disclosed |
| EP-1498178-B1 | Transition metal complex and process for producing the same | SUMITOMO CHEMICAL CO (JP) | 2008-06-11 | — | — | EP | disclosed |
| US-20060111525-A1 | Transition metal complexes, ligands, catalysts for olefin polymerization, and process for production of olefin polymers | HANAOKA HIDENORI | 2006-05-25 | — | — | US | disclosed |
| US-20050154158-A1 | Transition metal complexes, ligands, polymerization catalysts for olefins, and process for production of olefin polymers | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2005-07-14 | — | — | US | disclosed |
| EP-1498178-A2 | Transition metal complex, process for producing the same, olefin polymerization catalyst containing the transition metal complex and process for producing olefin polymers | Sumitomo Chemical Company, Limited (JP) | 2005-01-19 | — | — | EP | disclosed |
| EP-1475383-A1 | TRANSITION METAL COMPLEXES, LIGANDS, POLYMERIZATION CATALYSTS FOR OLEFINS, AND PROCESS FOR PRODUCTION OF OLEFIN POLYMERS | Sumitomo Chemical Company, Limited (JP) | 2004-11-10 | — | — | EP | disclosed |
| EP-0963990-B1 | PROCESS FOR PRODUCING CYCLOPENTADIENYL METAL SALTS AND PROCESS FOR PRODUCING CYCLOPENTADIENE DERIVATIVES BY UTILIZING THE SAME | SUMITOMO CHEMICAL CO (JP) | 2004-10-06 | — | — | EP | disclosed |
| EP-0842939-B1 | OLEFIN POLYMERIZATION CATALYST CONTAINING A TRANSITION METAL COMPLEX AND PROCESS FOR PRODUCING OLEFIN POLYMERS | SUMITOMO CHEMICAL CO (JP) | 2004-10-06 | — | — | EP | disclosed |
| US-6329478-B1 | SOLUBILITY IN SATURATED HYDROCARBON SOLVENTS | SUMITMO CHEMICAL COMPANY, LIMITED | 2001-12-11 | — | — | US | disclosed |
| US-6197990-B1 | REACTING CYCLOPENTADIENE AND METAL HYDRIDE IN PRESENCE OF AMINE COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2001-03-06 | — | — | US | disclosed |
| EP-0963990-A1 | PROCESS FOR PRODUCING CYCLOPENTADIENYL METAL SALTS AND PROCESS FOR PRODUCING CYCLOPENTADIENE DERIVATIVES BY UTILIZING THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1999-12-15 | — | — | EP | disclosed |
| EP-0842939-A1 | TRANSITION METAL COMPLEX, PROCESS FOR THE PREPARATION THEREOF, POLYMERIZATION CATALYST FOR OLEFINS CONTAINING THE COMPLEX, AND PROCESS FOR PRODUCING OLEFIN POLYMERS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1998-05-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210139617-A1 | NOVEL TRANSITION METAL COMPOUND, CATALYST COMPOSITION INCLUDING THE SAME, AND METHOD FOR PREPARING ETHYLENE HOMOPOLYMER OR COPOLYMER OF ETHYLENE AND ALPHA-OLEFIN USING THE SAME | NOTUM, ALOX12, ETFA | CYP3A4 1298/4885CYP2D6 2643/4885CA12 1156/4885 |
| US-20050154158-A1 | Transition metal complexes, ligands, polymerization catalysts for olefins, and process for production of olefin polymers | PYM1, OR10J3, AP1M1 | CYP3A4 383/4885CYP2D6 565/4885CA12 3823/4885 |
| US-11339230-B2 | Transition metal compound, catalyst composition including the same, and method for preparing ethylene homopolymer or copolymer of ethylene and α-olefin using the same | NOTUM, ALOX12, ETV6 | CYP3A4 1287/4885CYP2D6 2425/4885CA12 934/4885 |
| US-20080161514-A1 | Transition Metal Complex, Process For Producing Said Transition Metal Complex, Substituent-Carrying Fluorene Compound, Process For Producing Said Fluorene Compound, Catalyst Component For Olefin Polymerization, Catalyst For Olefin Polymerization, and Process For Producing Olefin Polymer | AOC2, ACSL1, ACSL3 | CYP3A4 147/4885CYP2D6 297/4885CA12 2292/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.